| Primary |
|
| Urine Output Decreased |
100.0% |
|
| Secondary |
| Hypertension |
47.8% |
| Drug Use For Unknown Indication |
5.8% |
| Rheumatoid Arthritis |
4.9% |
| Hyperlipidaemia |
3.6% |
| Back Pain |
3.5% |
| Prostate Cancer |
3.3% |
| Completed Suicide |
3.2% |
| Type 2 Diabetes Mellitus |
2.9% |
| Insomnia |
2.6% |
| Constipation |
2.4% |
| Mineral Supplementation |
2.4% |
| Diabetes Mellitus |
2.3% |
| Gastritis |
2.3% |
| Gastritis Prophylaxis |
2.3% |
| Cardiac Failure |
2.0% |
| Hypercholesterolaemia |
1.9% |
| Product Used For Unknown Indication |
1.9% |
| Acute Respiratory Distress Syndrome |
1.7% |
| Ill-defined Disorder |
1.7% |
| Dyslipidaemia |
1.6% |
|
| Loss Of Consciousness |
9.3% |
| Hepatic Function Abnormal |
8.3% |
| Sudden Hearing Loss |
8.3% |
| Toxic Epidermal Necrolysis |
8.3% |
| Pyrexia |
7.4% |
| Liver Disorder |
6.5% |
| Interstitial Lung Disease |
5.6% |
| Tooth Loss |
4.6% |
| Drug Eruption |
3.7% |
| Hypotension |
3.7% |
| Leukocytoclastic Vasculitis |
3.7% |
| Multi-organ Failure |
3.7% |
| Road Traffic Accident |
3.7% |
| Sensory Disturbance |
3.7% |
| Spinal Compression Fracture |
3.7% |
| Suicide Attempt |
3.7% |
| Vomiting |
3.7% |
| Bradycardia |
2.8% |
| Intervertebral Disc Protrusion |
2.8% |
| Iron Deficiency Anaemia |
2.8% |
|
| Concomitant |
| Hypertension |
43.2% |
| Product Used For Unknown Indication |
6.7% |
| Prophylaxis |
6.3% |
| Rheumatoid Arthritis |
5.9% |
| Diabetes Mellitus |
5.4% |
| Drug Use For Unknown Indication |
3.7% |
| Hyperlipidaemia |
3.1% |
| Hepatitis C |
2.7% |
| Insomnia |
2.5% |
| Constipation |
2.5% |
| Chronic Hepatitis C |
2.2% |
| Cardiac Failure |
2.2% |
| Gastritis |
2.2% |
| Angina Pectoris |
1.8% |
| Hyperuricaemia |
1.7% |
| Atrial Fibrillation |
1.7% |
| Type 2 Diabetes Mellitus |
1.7% |
| Hypercholesterolaemia |
1.7% |
| Osteoporosis |
1.7% |
| Nephrogenic Anaemia |
1.4% |
|
| Interstitial Lung Disease |
10.2% |
| Vomiting |
7.6% |
| Pneumonia |
7.4% |
| Renal Impairment |
7.4% |
| Death |
6.2% |
| Rash |
5.7% |
| Cerebral Infarction |
5.1% |
| Renal Failure Acute |
5.1% |
| Rhabdomyolysis |
4.8% |
| Malaise |
4.5% |
| Pyrexia |
4.5% |
| Decreased Appetite |
4.0% |
| Loss Of Consciousness |
4.0% |
| Urinary Tract Infection |
3.7% |
| White Blood Cell Count Decreased |
3.7% |
| Hyperkalaemia |
3.4% |
| Renal Failure |
3.4% |
| Cardiac Failure |
3.1% |
| Liver Disorder |
3.1% |
| Renal Disorder |
3.1% |
|
| Interacting |
| Dementia Alzheimer's Type |
66.7% |
| Product Used For Unknown Indication |
33.3% |
|
| Upper Respiratory Tract Inflammation |
100.0% |
|
